Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

IgM Antibody (IM373), PE/Atto594, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP234650PEATT594

Catalog No. N234650P594


Only null left
Add to Cart

Description

Description

IgM Monoclonal specifically detects IgM in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

IgM
Monoclonal
PE/ATTO 594
PBS with 0.05% Sodium Azide
IGHM
Recombinant heavy chain of human IgM
0.1 mL
Primary
Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This monoclonal antibody is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.
Store at 4°C in the dark. Do not freeze.
Flow Cytometry
IM373
Flow Cytometry
AGM1, DKFZp686I15196, DKFZp686I15212, FLJ00385, immunoglobulin heavy constant mu, MGC104996, MGC52291, MU, VH
Mouse
Protein A or G purified
B Cell Development and Differentiation Markers, Immunology
3507.0
Human
IgG2b κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.